RAPS recognizes that the current situation in Ukraine impacts our members and customers on many levels. If you are directly impacted by the current situation in the region and are challenged to meet your deadlines or obligations to RAPS, please reach out to raps@raps.org so that we can defer those challenges. Your health and safety are paramount to us.

Regulatory Focus™ > News Articles > Brazilian Consumers Allowed to Purchase OTC Drug Products Under New Rules

Brazilian Consumers Allowed to Purchase OTC Drug Products Under New Rules

Posted 30 July 2012 | By Ansis Helmanis

Brazilian consumers will not be able to purchase over-the-counter drug products at pharmacies according to new rules published 17 July 2012 by Brazilian health regulator Anvisa.

Under the new rules, the OTC products may be purchased in a manner similar to cosmetics and dietary supplements,regulators explained.

OTC drugs must be organized on pharmacy shelves by active ingredient with the cautionary statement that drugs may cause unwanted side effects.  Anvisa opened a public consultation in April 2012 that led to the reversal of a 2009 decision restricting OTC drugs to being kept behind the counter.


Read more:

Anvisa - OTC medications may be within reach of the consumer

Read all Breaking News from RegLink

 

© 2022 Regulatory Affairs Professionals Society.